Cognitive impairment is a significant cause of disability for many people with Multiple Sclerosis. To alleviate or slow the progression of cognitive impairment, non-drug interventions are studied – but which are the most promising?     On this episode, Dr. Mark Bayley interviews Dr. Katherine Knox and Dr. Sarah Morrow about the key findings from MSBEST’s systematic review on non-drug interventions evaluating cognitive impairment in MS. They discuss which interventions may help, clinical...

Cognitive impairment is a significant cause of disability for many people with Multiple Sclerosis (MS). To alleviate or slow the progression of cognitive impairment, pharmacological interventions are studied – but do they work? On this episode, Dr. Katherine Knox and Dr. Sarah Morrow share key findings from MSBEST’s systematic review on pharmacological interventions for cognitive impairment in MS. They discuss which interventions may help, which don’t work, and where more research is needed.